Why Are Biogen, Pfizer, And GSK Trading At A Discount?
(MENAFN- Baystreet) Last week, Biogen (BIIB) closed near a 52-week low of $150.03. The stock trades at a discount because the biotech firm lacks growth catalysts. Demand for Biogen's Alzheimer's drug, Leqembi, is still slow. Although analysts at …